Trials / Completed
CompletedNCT00626366
Distribution of Topical Nasal Medication Within the Nasal Cavity and Sinuses by Radiographic Comparison
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 18 (actual)
- Sponsor
- University of Nebraska · Academic / Other
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine the distribution of nasal sprays and nasal drops when used.
Detailed description
The purpose of this study is to determine the distribution of nasal sprays and nasal drops when used. The study hypothesizes that nasal drops will reach the frontonasal region more often than nasal sprays.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | Sinus CT Scan | Subjects will undergo a Xoran miniCAT scan of their sinuses |
| DRUG | Omnipaque 240 Contrast Solution | Subjects will spray 2-4 drops of half-strength Omnipaque 240 mgI/mL into each nare. Each spray is approximately 0.1 ml. |
| DRUG | Omnipaque 240 mg I/mL | Subjects will place two drops of half-strength Omnipaque 240 mg I/mL intranasally to each nose. Each drop is approximately 1 ml. |
Timeline
- Start date
- 2008-03-12
- Primary completion
- 2009-01-09
- Completion
- 2009-01-09
- First posted
- 2008-02-29
- Last updated
- 2023-09-28
- Results posted
- 2019-08-15
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00626366. Inclusion in this directory is not an endorsement.